“No hemos llegado al final de la pandemia: aún estamos en el túnel y hay muchos obstáculos que pueden hacernos tropezar: brechas de vacunación, bajos índices de pruebas y secuenciación, así como falta de acceso a antivirales”, advirtió el lunes 26 de septiembre el director general de la Organización Mundial […]
Read More
Summary What is already known about this topic? COVID-19 vaccines have been effective in preventing SARS-CoV-2 infection and associated hospitalizations and deaths among nursing home residents. What is added by this report? In a large cohort of nursing home residents, receipt of a second mRNA COVID-19 booster dose during circulation […]
Read More
Una revisión, disponible en un servidor de preimpresión, de 52 estudios sobre la efectividad de las vacunas disponibles contra la COVID-19 luego de aplicar los refuerzos encontró que:[1] Incluso con refuerzo todas las vacunas disponibles contra la COVID-19 tienen una menor efectividad (52,5%) para evitar infección sintomática por ómicron que la que […]
Read More
If you have heart disease, or have survived a heart attack or stroke, you know it can be challenging – even during normal times. COVID-19 has added another layer of worry, leaving many people with heart disease and other conditions on even higher alert than usual to stay healthy. Experts […]
Read More
Despite significant progress over the last few decades, meningitis remains a much-feared disease worldwide with a high case fatality rate and a propensity to cause epidemics that present a major challenge for health systems, economies and society. Meningitis caused an estimated 250 000 deaths in 2019, leaving one in five […]
Read More
Worldwide childhood vaccinations continued to decline in 2021, fueled by a multitude of factors from COVID-19 to challenging immunization settings, according to a statement by the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF). The percentage of children who received 3 doses of the vaccine against diphtheria-tetanus-pertussis (DTP)—a marker […]
Read More
El pasado domingo 18 de septiembre, el presidente de Estados Unidos, Joe Biden, declaró como terminada la pandemia de COVID-19 en Estados Unidos; sin embargo, una nueva subvariante del virus que causa la enfermedad podría dar un duro revés a las declaraciones del mandatario y al curso mismo de la pandemia. Hablamos de […]
Read More
This site provides an integrated, county view of key data for monitoring the COVID-19 pandemic in the United States. It allows for the exploration of standardized data across the country.§ The footnotes describe each data source and the methods used for calculating the metrics. For the most complete and up-to-date data […]
Read More
You will learn about the signs and symptoms of monkeypox, how it spreads, understanding your risk, and how to prevent and treat monkeypox. You’ll also hear about the trends for the current outbreak in the United States, how CDC is responding to and working toward reducing stigma surrounding monkeypox, and […]
Read More
Tixagevimab-cilgavimab is a combination medication to help prevent COVID-19 infection. Tixagevimab-cilgavimab (Evusheld) consists of 2 long-acting monoclonal antibodies that bind to the spike protein of the virus that causes COVID-19 to prevent it from infecting human cells. When Can Tixagevimab-Cilgavimab Be Given? Tixagevimab-cilgavimab is not a treatment for COVID-19 and […]
Read More